Consistent with the results shown in Fig 4, non-treated OFs from patients with TAO showed higher levels of IKKα/β and p65 phosphorylation, and a higher level of IκB degradation, compared to controls (Fig 6). The gene discussed is CHUK; the disease is thromboangiitis obliterans.